FOLH1 and posterior cortical atrophy: These findings confirmed our hypothesis regarding the prognostic value of PSMA-PET in recurrent HSPC patients with low PSA values, based on previous literature evidence showing the role of choline-PET and PSMA-PET in predicting PCa patients’ survival [19–25].